Filters
Maternal physical activity before and during pregnancy appears to have favourable effects of the neurodevelopment of children, as reported in a study.
Cumulative angiotensin II–stimulating (vs angiotensin II–inhibiting) antihypertensive exposure is associated with lower risk of certain dementia-related neuropathologies, a US study has found.
Treatment with the transthyretin stabilizer tafamidis helps lower mortality and reduce hospital readmissions for acute heart failure in octogenarian patients with transthyretin cardiac amyloidosis, as shown in a study.
Preventing respiratory syncytial virus (RSV) in infants can be achieved through maternal vaccination with the RSV prefusion F protein (RSVpreF) vaccine or administration of the monoclonal antibody nirsevimab—strategies endorsed by the WHO. In a French population-based cohort study, nirsevimab has been associated with lower risks of RSV-related hospitalizations and severe outcomes.
Treatment with REP 2139-Mg (REP), a nucleic acid polymer, demonstrates efficacy and an acceptable safety profile among patients with hepatitis D virus (HDV) and advanced chronic liver disease (CLD), reports a recent study.
A genetically engineered pig liver has been successfully transplanted in a living human, according to a recent study, noting the challenge posed by postoperative xenotransplantation-associated thrombotic microangiopathy (xTMA) to long-term success.
A recent study has shown the comparable effectiveness of fixed (fCPAP) and auto-titrating continuous positive airway pressure (APAP), with some outcomes favouring fCPAP, in patients with obesity hypoventilation syndrome (OHS) and severe obstructive sleep apnoea (sOSA).
A cross-sectional analysis presented at ISC 2026 suggests that a decline in mobility is an earlier functional manifestation of covert cerebral small vessel disease (CSVD) than cognitive impairment.
Treatment with the oral interleukin-1β blocker diacerein appears minimally beneficial for reducing pain in patients with knee osteoarthritis (OA), as shown in a study.
Treatment with either nifedipine or labetalol is equally effective in controlling blood pressure (BP) among women with hypertension during pregnancy, with no adverse effects on perinatal outcomes, according to the Giant PANDA* trial presented at SMFM 2026.
